SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Global Blood Therapeutics (GBT)

GBT RSS Feed
Add GBT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 11/3/2017 10:26:09 AM - Followers: 9 - Board type: Free - Posts Today: 0

Global Blood Therapeutics is biopharmaceutical firm that develops therapeutics for blood-based disorders. Its lead product candidate is GBT440, a once-daily oral prophylactic therapy for sickle cell disease (SCD), currently in Phase 1/2 development. GBT440 also being developed for the treatment of acute and chronic hypoxemic(inadequate levels of oxygen in the blood) pulmonary disorders. Additionally, its pipeline includes several small molecule kallikrein inhibitors for the prevention of angioedema attacks. SCD affects ~100K Americans and ~60K Europeans each year. The global incidence is ~300K per year. 2014 Financials ($M): Operating Expenses: 20.5 (+31.0%); Net Loss: (20.8) (-14.9%); Cash Burn: (20.1) (-36.9%).
SureTrader
Interactive Brokers Advertisement
GBT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
GBT News: GBT Announces Presentation of Six Studies at ASH Supporting Voxelotor Sickle Cell Disease (SCD) Program 12/11/2017 07:00:00 AM
GBT News: GBT Announces New Phase 2a Data at ASH for Voxelotor in Adolescents with Sickle Cell Disease (SCD) 12/09/2017 10:00:00 AM
GBT News: GUERBET : Gadolinium-based contrast agents: update on MHLW decision in Japan 12/06/2017 12:05:27 PM
GBT News: GUERBET : Gadolinium-based contrast agents: update on MHLW decision in Japan 12/06/2017 12:04:28 PM
GBT News: GUERBET : Produits de contraste à base de gadolinium : information sur la décision du Ministère de la Santé au Japon 12/06/2017 12:04:28 PM
PostSubject
#23   $GBT Reports Recent Business Progress and Provides Third Maxgambit 11/03/17 10:26:08 AM
#22   https://seekingalpha.com/article/4115611-global-blood-therapeutics-drops-idiopat Inoviorulez 10/23/17 06:54:16 PM
#21   Since selling half my shares @ $37.50, I Transparency 05/09/17 12:09:06 PM
#20   Between upcoming data points (adolescent SCD, IPF, & eneels01 05/06/17 09:53:38 AM
#18   She is busting out now! Transparency 03/09/17 12:31:28 PM
#17   GBT bearish 17.50 stocktrademan 12/05/16 11:58:36 AM
#16   What a beast ClearlyStocks 08/12/16 06:18:53 PM
#15   Well that was good for a pop to Whalatane 06/16/16 11:52:38 AM
#14   A dead Board ...may be a good sign ..:>) Whalatane 06/02/16 07:43:12 PM
#13   Movers and Shakers: The Week so Far - venturecapp 12/08/15 01:20:46 PM
#12   EPS= -1.51 TREND1 08/20/15 02:39:05 PM
#11   There is not enough data on the chart TREND1 08/19/15 11:51:50 PM
#10   Oh I see you posted a chart, pics protagonist12 08/19/15 11:51:00 PM
#9   I would like to know what your take protagonist12 08/19/15 11:49:23 PM
#8   What do you want to know about ? TREND1 08/19/15 11:48:48 PM
#7   What about it? protagonist12 08/19/15 11:44:52 PM
#6   GBT daily chart TREND1 08/19/15 11:41:12 PM
#5   GBT D? protagonist12 08/19/15 11:38:36 PM
#4   GBT D 4 MONTHS TREND1 08/19/15 10:07:36 PM
#3   Yeah not thrilled about it pricing $2 above protagonist12 08/11/15 10:08:21 PM
#2   Worth 20? Not really sure, if thats it librarianlover 08/11/15 09:16:44 PM
#1   Global Blood Therapeutics, an early-stage biotech developing a protagonist12 08/11/15 07:07:04 PM
PostSubject